TSXV:LNGE - Post Discussion
Post by
AwareInvestor on Feb 17, 2021 7:27am
Mind Cure Health Focuses On Research Into Psychedelics For T
Mind Cure Health as of this morning has seen the transition of one of its advisory board members to that of primary investigator consultant. Dr Dan Engle will be transitioning to the new role, as the company begins focusing on its research into the treatment of traumatic brain injury with psychedelics.
Be the first to comment on this post